Recent Posts

1. 

   Adstiladrin

   Not sure he signed one....My friend is a HCP who asked me when he left Ferring since he is calling on the HCP with another uro drug.....I said he didnt leave!! More power to him.

   Ferring

   anonymous

   Apr 19, 2024 at 8:23 AM

2. 

   Sight Sciences

   Any Tear Care payor wins? answer = NO. answer in 6 months will = NO Answer in a year = NO answer will = NO so keep kissing arse because market access is lieing to YOU

   Ophthalmology

   anonymous

   Apr 19, 2024 at 8:21 AM

3. 

   Sotyktu floundering

   they have a 4% share like everyone else but got a few that originated in Ohio and NJ that got filled in Boca with snowbird status, so they won

   Bristol-Myers Squibb

   anonymous

   Apr 19, 2024 at 8:15 AM

4. 

   25 by 25

   Agree. They are pillaging the culture of the company, the focus of the company and the resources. Will not turn around until they are removed or we break it up and sell the pieces. Question: if PFE sold off pieces, would you hope to stay in...

   Pfizer

   anonymous

   Apr 19, 2024 at 8:12 AM

5. 

   TGIF

   Fryday yeah

   Azurity Pharmaceuticals

   anonymous

   Apr 19, 2024 at 8:10 AM

6. 

   What happened to allen labrune?

   Allen LaBrune left in February. Diane Deloria left mid-April, both went other companies. Chris Villani who was over the immunology zeposia reimbursement team left for another division within BMS. The market access reimbursement team has no...

   Bristol-Myers Squibb

   anonymous

   Apr 19, 2024 at 8:07 AM

7. 

   CMX is a train wreck

   We will hear on Monday, CMX is sadly a part of it. At least one Team leader and an associate from each group are being let go. R&D has always been dead at BMS in the last 10 years.

   Bristol-Myers Squibb

   anonymous

   Apr 19, 2024 at 8:03 AM

8. + Show More